NCT01665963Unknown不适用
Efficacy of TopClosure(C)System in Healing Complicated Pacemaker Wounds
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- Efficacy of TopClosure(c) System
研究概览
简要总结
Patients receiving oral anticoagulation or anti-platelet therapy are at high risk of hematoma after device implantation. This study intends to examine the efficacy of the TopClosure(c) System in wound healing in these patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Care Provider)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients treated with anticoagulant therapy
- •Patients treated with antiplatelet therapy
排除标准
- 未提供
结局指标
主要结局
Efficacy of TopClosure(c) System
时间窗: 10 days
Outside surgeon (blinded) will determine whether wound has healed
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein StentingDeep Vein ThrombosisIliac Vein ThrombosisIliac Vein ObstructionIliac Vein StenosisIliac Vein Compression SyndromeNCT04694248First Affiliated Hospital of Zhejiang University172
招募中
3 期
Avoiding Anticoagulation After IntraCerebral HaemorrhageIntracerebral HemorrhageMicrohaemorrhageAtrial FibrillationNCT03243175University Hospital, Lille300
已完成
不适用
Eosinophil and Anticoagulation in COVID-19 PatientsCOVID-19NCT04507282Bursa Postgraduate Hospital80
Unknown
不适用
SAfety and EFficacy of Bridging Antithrombotic Therapy During Elective Non-cardiac SurgeryCoronary Artery DiseaseNCT04675801Beijing Anzhen Hospital950
已完成
不适用
Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 PatientsCovid-19Thromboembolic EventsBleedingNCT04412304Karolinska Institutet166